Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
WHIM syndrome is an immunodeficiency disease characterized by neutropenia, hypogammaglobulinemia and extensive human papillomavirus (HPV) infection. Despite the peripheral neutropenia, bone marrow aspirates from affected individuals contain abundant mature myeloid cells, a condition termed myelokathexis. The susceptibility to HPV is disproportionate compared with other immunodeficiency conditions, suggesting that the product of the affected gene may be important in the natural control of this infection. We describe here the localization of the gene associated with WHIM syndrome to a region of roughly 12 cM on chromosome 2q21 and the identification of truncating mutations in the cytoplasmic tail domain of the gene encoding chemokine receptor 4 (CXCR4). Haplotype and mutation analyses in a pedigree transmitting myelokathexis as an apparently autosomal recessive trait support genetic heterogeneity for this aspect of the WHIM syndrome phenotype. Lymphoblastoid cell lines carrying a 19-residue truncation mutation show significantly greater calcium flux relative to control cell lines in response to the CXCR4 ligand, SDF-1, consistent with dysregulated signaling by the mutant receptor. The identification of mutations in CXCR4 in individuals with WHIM syndrome represents the first example of aberrant chemokine receptor function causing human disease and suggests that the receptor may be important in cell-mediated immunity to HPV infection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Alterations in GPCR signalling are implicated in the pathogenesis and treatment of neuropsychiatric55, immunological56, gastrointestinal57,58, cardiac59, renal, hormonal, infectious60 and many other disorders53,54.”
From Unexplored therapeutic opportunities in the human genome (2018) · cites this paper as [56]
Citations
Cites
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor
Feng, Y., Broder, C. C., Kennedy, P. E., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5263.872 · Cited by 4,172
Identification of a major co-receptor for primary isolates of HIV-1
Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Marzio, P. D., Marmon, S., Sutton, R. E., Hill, C. M., et al. (1996) · Nature · doi:10.1038/381661a0 · Cited by 3,641 · cited 1×
“To date, their role in disease causation has been best established for the co-receptor function of CCR5 and CXCR4 in HIV infectio”
BackgroundParametric and nonparametric linkage analysis: a unified multipoint approach.
Kruglyak, L., Daly, M. J., Daly, M. J., & Lander, E. S. (1996) · PubMed · Cited by 2,877
Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development
Zou, Y.-R., Kottmann, A. H., Kuroda, M., Taniuchi, I., & Littman, D. R. (1998) · Nature · doi:10.1038/31269 · Cited by 2,489
Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S.-I., Kitamura, Y., Yoshida, N., Kikutani, H., & Kishimoto, T. (1996) · Nature · doi:10.1038/382635a0 · Cited by 2,338
Ma, Q., Jones, D., Borghesani, P. R., Segal, R. A., Nagasawa, T., Kishimoto, T., Bronson, R. T., & Springer, T. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9448 · Cited by 1,682
The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract
Tachibana, K., Hirota, S., Iizasa, H., Yoshida, H., Kawabata, K., Kataoka, Y., Kitamura, Y., Matsushima, K., Yoshida, N., Nishikawa, S.-I., et al. (1998) · Nature · doi:10.1038/31261 · Cited by 1,525
Multilocus linkage analysis in humans: detection of linkage and estimation of recombination.
Lathrop, M. G., Lalouel, J.-M., Julier, C., & Ott, J. (1985) · Europe PMC (PubMed Central) · Cited by 1,228
Burger, J. A., Tsukada, N., Burger, M., Zvaifler, N. J., Dell'Aquila, M., & Kipps, T. J. (2000) · Blood · doi:10.1182/blood.v96.8.2655 · Cited by 607 · cited 1×
“Moreover, CXCR4 and SDF-1 signaling has been shown to inhibit spontaneous apoptosis in human chronic lymphocytic leukemia B cell”
Background
Cited by
Items 201–300 of 724
A phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndrome
Badolato, R., Alsina, L., Azar, A., Bertrand, Y., Bolyard, A. A., Dale, D. C., Deyà‐Martínez, À., Dickerson, K. E., Ezra, N., Hasle, H., et al. (2024) · Blood · doi:10.1182/blood.2023022658 · Cited by 58
Tassone, L., Notarangelo, L. D., Bonomi, V., Savoldi, G., Sensi, A., Soresina, A., Smith, C. I. E., Porta, F., Plebani, A., Notarangelo, L. D., et al. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.12.1133 · Cited by 58
Using nanoBRET and CRISPR/Cas9 to monitor proximity to a genome-edited protein in real-time
White, C., Vanyai, H., See, H. B., Johnstone, E. K. M., & Pfleger, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-03486-2 · Cited by 49
Different Faces for Different Places: Heterogeneity of Neutrophil Phenotype and Function
Yang, P., Li, Y., Xie, Y., & Liu, Y. (2019) · Journal of Immunology Research · doi:10.1155/2019/8016254 · Cited by 74
“Neutrophils in circulation CXCR4CXCR2CD62L Migration [21, 23]”
BackgroundInfluentialTherapeutic Targeting of Neutrophil Granulocytes in Inflammatory Liver Disease
Bartneck, M., & Wang, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02257 · Cited by 60
“Appropriate signals can rapidly recruit neutrophils if required (16, 17).”
BackgroundLymphoid differentiation of hematopoietic stem cells requires efficient Cxcr4 desensitization
Freitas, C., Wittner, M., Nguyen, J., Rondeau, V., Biajoux, V., Aknin, M.-L. R., Gaudin, F., Beaussant, S. C., Bertrand, Y., Bellanné‐Chantelot, C., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20160806 · Cited by 61
“This results in the distal truncation of the C-tail of CXCR4 and a desensitization- and internalization-resistant receptor in response to CXCL12 (Hernandez et al., 2003; Balabanian et al., 2005).”
BackgroundOligoclonality, impaired class switch and B-cell memory responses in WHIM syndrome
Guire, P. J. M., Cunningham‐Rundles, C., Ochs, H. D., & Diaz, G. A. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.02.006 · Cited by 56
“[1] The genetic basis of WHIM syndrome is mutation of the chemokine receptor CXCR4.[2] All mutations described to date are heterozygous nonsense or frameshift lesions that result in truncations of the cytoplasmic tail of the receptor.”
BackgroundMethodSelf-citationThe Secretive Life of Neutrophils Revealed by Intravital Microscopy
Filippo, K. D., & Rankin, S. M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.603230 · Cited by 54
“The impact of circadian rhythms on neutrophil mobilization, clearance, and inflammation has been more extensively reviewed here (Scheiermann et al., 2013; Hidalgo et al., 2019; Adrover et al., 2020; Aroca-Crevillen et al., 2020).”
BackgroundThe molecular pharmacology of AMD11070: An orally bioavailable CXCR4 HIV entry inhibitor
Mosi, R., Anastassova, V., Cox, J. H., Darkes, M. C., Idzan, S. R., Labrecque, J., Lau, G., Nelson, K. L., Patel, K., Santucci, Z., et al. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.11.020 · Cited by 55
“Mutations in CXCR4 resulting in truncation of the intracellular C-terminus of the receptor have been linked to the rare autoimmune disease, WHIM syndrome [35,36].”
BackgroundFioredda, F., Calvillo, M., Bonanomi, S., Coliva, T. A., Tucci, F., Farruggia, P., Pillon, M., Martire, B., Ghilardi, R., Ramenghi, U., et al. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23108 · Cited by 60
“Neutropenias with immunodeficiency Severe congenital neutropenia þ immunodeficit WAS [54,55] X-linked Severe congenital neutropenia þ immunodeficit GFI1 [22] AD WHIM syndrome CXCR4 [23] AD Cohen syndrome COH [24] AR X-linked hypoagammaglobulinemia BTK [25,26,27] X-linked Hyper IgM CD40L [28,33] X-linked Neutropenias w…”
BackgroundNeutrophil Reverse Migration Becomes Transparent with Zebrafish
Starnes, T. W., & Huttenlocher, A. (2012) · Advances in Hematology · doi:10.1155/2012/398640 · Cited by 66
“Failure to internalize the CXCR4 receptor prevents downregulation of CXCR4-mediated signalling and is responsible for the retention of neutrophils in the bone marrow or caudal hematopoietic tissue of WHIM syndrome patients and a zebrafish model of WHIM syndrome, respectively [24, 64–67].”
BackgroundKreuter, A. (2008) · Archives of Dermatology · doi:10.1001/archderm.144.3.366 · Cited by 54
“In WHIM syndrome, mutations of CXCR4 have been demonstrated to predispose for HPV infection by aberrant chemokine receptor function.(27) The presence of WHIM syndrome in our patient was excluded by chemokine receptor gene CXCR4 analysis.”
BackgroundCabral-Marques, O., Schimke, L., Pereira, P. V. S., Falcai, Â., Oliveira, J. B., Hackett, M. J., Errante, P. R., Weber, C. W., Ferreira, J. F. S., Kuntze, G., et al. (2011) · Journal of Clinical Immunology · doi:10.1007/s10875-011-9623-6 · Cited by 54
Freitas, C., Desnoyer, A., Meuris, F., Bachelerie, F., Balabanian, K., & Machelon, V. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.04.006 · Cited by 61
“WS is caused by CXCL12-dependent axis dysfunctions, mainly as a consequence of inherited heterozygous autosomal dominant gain-of-function mutations in the CXCR4 gene [88].”
BackgroundIdiopathic CD4 lymphocytopenia: a case of missing, wandering or ineffective T cells
Zonios, D. I., Sheikh, V., & Sereti, I. (2012) · Arthritis Research & Therapy · doi:10.1186/ar4027 · Cited by 56
“In an immunodefi ciency syndrome characterized by warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM), mutations of the chemokine receptor CXCR4 leading to neutropenia and immunodefi ciency were identifi ed [17].”
BackgroundCXCL12/CXCR4-Axis Dysfunctions: Markers of the Rare Immunodeficiency Disorder WHIM Syndrome
Bachelerie, F. (2010) · Disease Markers · doi:10.1155/2010/475104 · Cited by 58
Choi, W., Yang, Y., Xu, Y., & An, J. (2014) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026614666140827143541 · Cited by 51
At the Bench: Pre-clinical evidence for multiple functions of CXCR4 in cancer
Luker, G. D., Yang, J., Richmond, A. J., Scala, S., Festuccia, C., Schottelius, M., Wester, H.-J., & Zimmermann, J. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.2bt1018-715rr · Cited by 57
Leukocyte circulation: one-way or round-trip? Lessons from primary immunodeficiency patients
Badolato, R. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1103529 · Cited by 52
“Diaz and co-workers [30] have recently identified heterozygous mutations of the gene encoding for CXC chemokine receptor 4 (CXCR4), the receptor for CXCL12, which result in partial truncation of the cytoplasmic tail in patients affected by WHIM syndrome.”
BackgroundDisease Progression of WHIM Syndrome in an International Cohort of 66 Pediatric and Adult Patients
Geier, C. B., Ellison, M., Cruz, R. J., Pawar, S., Leiss-Piller, A., Zmajkovicova, K., McNulty, S. M., Yilmaz, M., Evans, M. O., Gordon, S., et al. (2022) · Journal of Clinical Immunology · doi:10.1007/s10875-022-01312-7 · Cited by 51
“CXCL12 gradients and to egress from the bone marrow into periphery and/or to sites of inflammation [2, 5, 6].”
BackgroundHout, A. V., D’huys, T., Oeyen, M., Schols, D., & Loy, T. V. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176057 · Cited by 51
Neutrophil Homeostasis: A New Role for Stromal Cell–Derived Factor-1
Link, D. C. (2005) · Immunologic Research · doi:10.1385/ir:32:1-3:169 · Cited by 51
Chemokines, their receptors and human disease: the good, the bad and the itchy
Bryant, V. L., & Slade, C. A. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2015.23 · Cited by 56
Handisurya, A., Schellenbacher, C., Reininger, B., Koszik, F., Vyhnanek, P., Heitger, A., Kirnbauer, R., & Förster‐Waldl, E. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.04.057 · Cited by 63
“No CXCR4 mutations were detected in the patient’s two healthy siblings and her parents.”
InfluentialThe CXCL12/CXCR4 Signaling Pathway: A New Susceptibility Factor in Human Papillomavirus Pathogenesis
Meuris, F., Carthagéna, L., Jaracz‐Ros, A., Gaudin, F., Cutolo, P., Deback, C., Xue, Y., Thierry, F., Doorbar, J., & Bachelerie, F. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1006039 · Cited by 56
Inflammatory Bowel Disease and T cell Lymphopenia in G6PC3 Deficiency
Bégin, P., Patey, N., Mueller, P., Rasquin, A., Sirard, A., Klein, C., Haddad, É., Drouin, É., & Deist, F. L. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9833-6 · Cited by 49
“lymphopenia observed in G6PC3 deficiency as it does in the WHIM syndrome [17].”
Biased agonism at chemokine receptors
Eiger, D. S., Boldizsar, N. M., Honeycutt, C. C., Gardner, J., & Rajagopal, S. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109862 · Cited by 55
Schüller, U., Koch, A., Hartmann, W., Garrè, M. L., Goodyer, C. G., Cama, A., Sørensen, N. S., Wiestler, O. D., & Pietsch, T. (2005) · International Journal of Cancer · doi:10.1002/ijc.21116 · Cited by 49
Congenital neutropenia: advances in diagnosis and treatment
Badolato, R., Fontana, S., Notarangelo, L. D., & Savoldi, G. (2004) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/00130832-200412000-00007 · Cited by 49
Al Ustwani, O., Kurzrock, R., & Wetzler, M. (2014) · British Journal of Haematology · doi:10.1111/bjh.12574 · Cited by 48
“The reason behind the neutrophil retention/apoptosis in the bone marrow has been linked to aberrations in the chemokine receptor type-4 (CXCR4; CD184) (Hernandez et al, 2003).”
BackgroundPathogenesis, diagnosis and therapeutic strategies in WHIM syndrome immunodeficiency
Heusinkveld, L. E., Yim, E., Yang, A. Y., Azani, A. B., Liu, Q., Gao, J., McDermott, D. H., & Murphy, P. M. (2017) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2017.1375403 · Cited by 53
“2003 Gain-of-function mutations affecting the C-tail of CXCR4 are shown to cause WHIM syndrome [13].”
BackgroundInfluentialMiao, R., Lim, V., Kothapalli, N., Ma, Y., Fossati, J., Zehentmeier, S., Sun, R., & Pereira, J. P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.600127 · Cited by 55
Ok, S., Kim, S., Kim, C., Nam, D., Shim, B. S., Kim, S., Ahn, K. S., Choi, S., & Ahn, K. S. (2012) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2012.654494 · Cited by 47
“It is reported that it involves in induction of leukocyte trafficking,((14)) playing pivotal roles in B cell lymphopoiesis and myelopoiesis,((15)) gastrointestinal tract vascularization,((9)) neuronal and germ cell migration,((16,17)) and HIV invasion of host cells.”
BackgroundPetersen, D. C., Glashoff, R. H., Shrestha, S., Bergeron, J., Laten, A., Gold, B., van Rensburg, E. J., Dean, M. C., & Hayes, V. M. (2005) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000186360.42834.28 · Cited by 46
“Recently, mutations in the cytoplasmic tail domain of CXCR4 were identified as being causative for WHIM syndrome, an immunodeficiency disorder characterized by warts, hypogammaglobulinemia, infections, and myelokathexis.(38) These mutations, however, are familial and rare.”
BackgroundNovel genetic etiologies of severe congenital neutropenia
Boztuǧ, K., & Klein, C. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.09.003 · Cited by 50
Targeting chemokine receptors in disease – a case study of CCR4
Solari, R. C. E., & Pease, J. E. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.05.018 · Cited by 60
“These are remarkably similar to truncating mutations in CXCR4 that have been described as exacerbating signaling in WHIM syndrome patients (Hernandez et al., 2003).”
BackgroundNotarangelo, L. D., & Fleisher, T. A. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.01.004 · Cited by 46
Biondi, M., Tettamanti, S., Galimberti, S., Cerina, B., Tomasoni, C., Piazza, R., Donsante, S., Bido, S., Perriello, V. M., Broccoli, V., et al. (2023) · Blood · doi:10.1182/blood.2022018330 · Cited by 62
A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome
McDermott, D. H., Velez, D. S., Cho, E., Cowen, E. W., DiGiovanna, J. J., Pastrana, D. V., Buck, C. B., Calvo, K. R., Gardner, P. J., Rosenzweig, S. D., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci164918 · Cited by 45
“Two mutations, R334X and S338X, account for approximately 70% of cases (4, 9).”
CXCR4: from B-cell development to B cell–mediated diseases
Giorgiutti, S., Rottura, J., Korganow, A., & Gies, V. (2024) · Life Science Alliance · doi:10.26508/lsa.202302465 · Cited by 46
“In humans, gain-of-function (GOF) mutations in CXCR4 are associated with lymphopenia and hypogammaglobulinemia in the so-called WHIM (warts, hypogammaglobulinemia, infections, and myeloka-thexis) syndrome (Hernandez et al, 2003).”
BackgroundSchäffer, A. A., & Klein, C. (2007) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e3282f1d690 · Cited by 53
Malik, R., Soh, U. J. K., Trejo, J., & Marchese, A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.336792 · Cited by 46
“CXCR4-mediated signaling has also been linked tomultiple pathological conditions including WHIM (warts, hypogammaglobulinemia, infections, myelokathexis) syndrome and cancer progression (5, 6).”
BackgroundPathogenic mechanisms and clinical implications of congenital neutropenia syndromes
Hauck, F. H., & Klein, C. (2013) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000014 · Cited by 49
Approach to the Patient With Recurrent Infections
Ballow, M. C. (2007) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-007-8041-2 · Cited by 51
Diagnostic Assays for Chronic Granulomatous Disease and Other Neutrophil Disorders
Elloumi, H. Z., & Holland, S. M. (2007) · Methods in Molecular Biology™ · doi:10.1007/978-1-59745-467-4_31 · Cited by 44
Lai, C., Yamazaki, S., Okabe, M., Suzuki, S., Maeyama, Y., Iimura, Y., Onodera, M., Kakuta, S., Iwakura, Y., Nojima, M., et al. (2014) · Stem Cells · doi:10.1002/stem.1670 · Cited by 54
Calandra, G. C., Bridger, G. J., & Fricker, S. P. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_26 · Cited by 49
“In the majority of WHIM patients, the disease has been linked to autosomal dominant inherited mutations in the chemokine receptor CXCR4, causing truncations in the C-terminus (Hernandez et al. 2003; Gulino 2003; Gulino et al. 2004).”
BackgroundMonocyte, Macrophage, and Dendritic Cell Development: the Human Perspective
Collin, M. P., & Bigley, V. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0015-2015 · Cited by 52
Frater, J. L. (2020) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.13210 · Cited by 43
Neutrophil biology in injuries and diseases of the central and peripheral nervous systems
Balog, B. M., Sonti, A., & Zigmond, R. E. (2023) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2023.102488 · Cited by 51
Differences in CXCR4-mediated signaling in B cells
Palmesino, E., Moepps, B., Gierschik, P., & Thelen, M. (2006) · Immunobiology · doi:10.1016/j.imbio.2005.12.003 · Cited by 42
Pessach, I. M., Walter, J. E., & Notarangelo, L. D. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e31819dbe1e · Cited by 49
Boztuǧ, K., & Klein, C. (2012) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2012.11.004 · Cited by 41
Baek, S. H., Kim, S., Nam, D., Lee, J., Ahn, K. S., Choi, S., Kim, S., Shim, B. S., Chang, I., & Ahn, K. S. (2012) · Pharmaceutical Biology · doi:10.3109/13880209.2012.664151 · Cited by 40
“CXCR4 is the best characterized chemokine receptor, which has been shown to induce leukocyte trafficking (Hernandez et al., 2003), mediation of pivotal roles in B cell lymphopoiesis and myelopoiesis (Nagasawa et al., 1996), gastrointestinal tract vascularization (Taichman et al., 2002), neuronal…”
BackgroundContext-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3
Heuninck, J., Perpiñá-Viciano, C., Işbilir, A., Caspar, B., Capoferri, D., Briddon, S. J., Durroux, T., Hill, S. J., Lohse, M. J., Milligan, G., et al. (2019) · Molecular Pharmacology · doi:10.1124/mol.118.115477 · Cited by 47
Venkatesha, R. T., Ahamed, J., Nuesch, C., Zaidi, A. K., & Ali, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408035200 · Cited by 40
Sporadic case of warts, hypogammaglobulinemia, immunodeficiency, and myelokathexis syndrome
Tarzi, M. D., Jenner, M., Hattotuwa, K., Faruqi, A. Z., Díaz, G. A., & Longhurst, H. J. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.08.040 · Cited by 40
Congenital Neutropenia Syndromes
Boztuǧ, K., Welte, K., Zeidler, C., & Klein, C. (2008) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2008.01.007 · Cited by 40
“Most cases of WHIM syndrome follow an autosomal-dominant pattern of inheritance and show heterozygous gain-of-function mutations in chemokine receptor gene CXCR4 [53].”
BackgroundSuccessful umbilical cord blood stem cell transplantation in a child with WHIM syndrome
Kriván, G., Erdös, M., Kállay, K. M., Benyó, G., Tóth, Á., Sinkó, J., Goda, V., Tóth, B., & Maródi, L. (2009) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2009.01368.x · Cited by 39
“To the Editor: Warts hypogammaglobulinemia infections myelokathexis (WHIM) syndrome is an autosomal dominant primary immunodeficiency disorder caused by mutation of the cysteine-X-cysteine chemokine receptor 4 (CXCR4) gene (1, 2).”
BackgroundRole of reverse transendothelial migration of neutrophils in inflammation
Hirano, Y., Aziz, M., & Wang, P. (2016) · Biological Chemistry · doi:10.1515/hsz-2015-0309 · Cited by 41
Mahlknecht, U., & Schönbein, C. (2008) · Haematologica · doi:10.3324/haematol.11796 · Cited by 39
“Accordingly, both the inducible ablation of alpha4 integrins in adult mice, as well as in vivo treatment of mice with antibodies to VLA-4, resulted in the efficient mobilization of CD34 hematopoietic stem cells from the bone marrow and their release into the peripheral blood.(12,13) VLA-4 is known to function not only…”
BackgroundAtallah, M., Krispin, A., Trahtemberg, U., Benhamron, S., Grau, A., Verbovetski, I., & Mevorach, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029333 · Cited by 48
Primary immunodeficiency update
Pichard, D. C., Freeman, A. F., & Cowen, E. W. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.01.054 · Cited by 38
Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia
Martinelli, G. B., Olivari, D., Cecconi, A. D. R., Talamini, L., Ottoboni, L., Lecker, S. H., Stretch, C., Baracos, V. E., Bathe, O. F., Resovi, A., et al. (2016) · Oncogene · doi:10.1038/onc.2016.153 · Cited by 41
Tsou, L. K., Huang, Y., Song, J., Ke, Y., Huang, J., & Shia, K. (2017) · Medicinal Research Reviews · doi:10.1002/med.21464 · Cited by 42
A Chemoattractant-Guided Walk Through Lymphopoiesis
Lim, V., Zehentmeier, S., Fistonich, C., & Pereira, J. P. (2017) · Advances in immunology · doi:10.1016/bs.ai.2017.02.001 · Cited by 42
CXCR4 expression heterogeneity in neuroblastoma cells due to ligand-independent regulation
Carlisle, A. J., Lyttle, C. A., Carlisle, R. Y., & Maris, J. M. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-126 · Cited by 37
“In humans, genetic mutation of CXCR4 is associated with the clinical syndrome WHIM, in which a truncating mutation results in deregulation of receptor signaling and consequent impairment of leukocyte function [12,13].”
BackgroundChemokines as a Conductor of Bone Marrow Microenvironment in Chronic Myeloid Leukemia
Mukaida, N., Tanabe, Y., & Baba, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081824 · Cited by 39
“WHIM (wart, hypogammaglobulinemia, recurrent infections, and myelokthexis) syndrome is an autosomal dominant combined primary immunodeficiency disease caused by loss of function mutations in CXCR4 [18].”
BackgroundPasset, M., Kim, R., Gachet, S., Sigaux, F., Chaumeil, J., Galland, A., Sexton, T., Quentin, S., Hernandez, L., Larcher, L., et al. (2022) · Blood · doi:10.1182/blood.2021014723 · Cited by 46
Badolato, R., Dotta, L., Tassone, L., Amendola, G., Porta, F., Locatelli, F., Notarangelo, L. D., Bertrand, Y., Bachelerie, F., & Donadieu, J. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.05.058 · Cited by 46
Kremer, K. N., Kumar, A., & Hedin, K. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1581 · Cited by 40
“In addition, rare mutations in CXCR4 that truncate CXCR4 and enhance some SDF-1-dependent signals are linked to WHIM syndrome, which is characterized by extensive human papillomavirus infection in addition to other pathologies (61).”
BackgroundBarker, B. L., & Benovic, J. (2011) · Biochemistry · doi:10.1021/bi2005202 · Cited by 36
“CXCR4 has been implicated in the progression of various disease states, including WHIM syndrome (35), human immunodeficiency virus-1 entry (36), and the progression of cancer (37).”
BackgroundHuman Papillomavirus ( HPV ) Genotyping of Cutaneous Warts in Greek Children
Giannaki, M., Kakourou, T., Theodoridou, M. N., Syriopoulou, V., Kabouris, M., Louizou, E., & Chrousos, G. P. (2013) · Pediatric Dermatology · doi:10.1111/pde.12113 · Cited by 36
“Specific cutaneous types have also been detected in epidermodysplasia verruciformis, a rare familial disorder related to the development of large cutaneous warts that can progress to skin cancer (7), and WHIM syndrome, a rare immunodeficiency syndrome characterized by warts, hypogammaglobulinemia, recurrent bacterial…”
BackgroundAltered chemotactic response to CXCL12 in patients carrying GATA2 mutations
Maciejewski‐Duval, A., Meuris, F., Bignon, A., Aknin, M.-L. R., Balabanian, K., Faivre, L. O., Pasquet, M., Barlogis, V., Fieschi, C., Bellanné‐Chantelot, C., et al. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.5ma0815-388r · Cited by 40
“nia that characterizes the WHIM syndrome [20, 21].”
CXCR4 signaling controls dendritic cell location and activation at steady state and in inflammation
Gallego, C., Vétillard, M., Calmette, J., Roriz, M., Marin‐Esteban, V., Evrard, M., Aknin, M.-L. R., Pionnier, N. P., Lefrançois, M., Mercier‐Nomé, F., et al. (2021) · Blood · doi:10.1182/blood.2020006675 · Cited by 41
Choi, W., Kumar, S., Madani, N., Han, X., Tian, S., Dong, C., Liu, D., Duggineni, S., Yuan, J., Sodroski, J., et al. (2012) · Biochemistry · doi:10.1021/bi2016712 · Cited by 38
“Another piece of evidence for CXCR4 dimerization involves the “warts, hypogammaglobulinemia, infections and myelokathexis” (WHIM) syndrome (34).”
BackgroundCXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndrome
de Wit, R. H., Heukers, R., Brink, H. J., Arsova, A., Maussang, D., Cutolo, P., Strubbe, B., Vischer, H. F., Bachelerie, F., & Smit, M. J. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.242735 · Cited by 35
“The disease is named after its main four clinical manifestations: human papillomavirus (HPV)–induced warts, hypogammaglobulinemia, recurrent bacterial infections, and myelokathexis (Gorlin et al., 2000; Hernandez et al., 2003).”
BackgroundTamura, S., Higuchi, K., Tamaki, M., Inoue, C., AWAZAWA, R., Mitsuki, N., Nakazawa, Y., Mishima, H., Takahashi, K., Kondo, O., et al. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.07.004 · Cited by 38
Inherited disorders of cytokines
Pïcard, C., & Casanova, J. (2004) · Current Opinion in Pediatrics · doi:10.1097/01.mop.0000145919.92477.5f · Cited by 42
Gauthier, A., Thauvin‐Robinet, C., Bruel, A., Duffourd, Y., St‐Onge, J., Jouan, T., Rivière, J., Héron, D., Donadieu, J., Bellanné‐Chantelot, C., et al. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37969 · Cited by 38
“…2014]); (ii) CNwith innate or adaptive deficiency but no extrahematopoietic features (GFI1 [Person et al., 2003], WAS [Ancliff et al., 2006], CXCR4 [Hernandez et al., 2003], STK4/ MST1 [Abdollahpour et al., 2012], GATA2 [Pasquet et al., 2013], ASXL1 [West et al., 2014]); and (iii) CN with…”
Minami, H., Nagaharu, K., Nakamori, Y., Ohishi, K., Shimojo, N., Kageyama, Y., Matsumoto, T., Sugimoto, Y., Tawara, I., Masuya, M., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700054 · Cited by 34
Genetic variation in CXCR4 and risk of chronic lymphocytic leukemia
Crowther-Swanepoel, D., Qureshi, M., Dyer, M. J. S., Matutes, E., Dearden, C. E., Catovsky, D., & Houlston, R. S. (2009) · Blood · doi:10.1182/blood-2009-07-235184 · Cited by 41
“rs56400844:157 AC No data† I53L 0.005 (1) rs2228014: 414 CT 0.043 Synonymous 0.037 ( 14 ) 415 GA — V139I 0.005 (1) 584 AG — W195X 0.005 (1) 1003 AG — G335S 0.005 (1) 1295 C G— 3 UTR 0.005 (1) 1350 G A— 3 UTR 0.005 (1) 1430 C T— 3 UTR 0.005 (1)”
InfluentialWHIM syndrome and oral squamous cell carcinoma
Cipriani, N. A., Blair, E. A., & Taxy, J. B. (2009) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2009.08.011 · Cited by 34
“The immune basis for WHIM syndrome may be related to a mutation in the chemokine receptor CXCR4, a 7-transmembrane protein expressed in a variety of stem and progenitor cells, including hematopoietic, neural and liver stem cells, primordial germ cells, and skeletal muscle and retinal progenitor cells.(11,12) The gene…”
BackgroundHummel, S., Aken, H. V., & Zarbock, A. (2013) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000002 · Cited by 35
“Unau 1065-6251 2013 Wolters Kluwer Health | Lippincott Williams & Wilk mutations that remove 10–19 amino acids from CXCR4 [43].”
BackgroundEmerging concepts and approaches for chemokine-receptor drug discovery
O’Hayre, M., Salanga, C. L., Handel, T. M., & Hamel, D. J. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2010.525633 · Cited by 33
“These receptors show enhanced signaling responses to CXCL12/SDF-1 as a consequence of their reduced ability to undergo ligand-mediated receptor desensitization and internalization [66,75].”
BackgroundCommon Variable Immunodeficiency: Test Indications and Interpretations
Weiler, C. R., & Bankers‐Fulbright, J. L. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.9.1187 · Cited by 38
Regulation of neutrophils in type 2 immune responses
Heeb, L. E. M., Egholm, C., Impellizzieri, D., Ridder, F., & Boyman, O. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.06.009 · Cited by 35
Tarrant, T. K., Billard, M. J., Timoshchenko, R. G., McGinnis, M. W., Serafín, D., Foreman, O., Esserman, D. A., Chao, N. J. A., Lento, W. E., Lee, D. M., et al. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0213097 · Cited by 32
“The most-affected WHIM kindreds possess functional mutations in the carboxy terminus of the CXCR4 chemokine receptor [3].”
BackgroundWHIM Syndrome Caused by Waldenström’s Macroglobulinemia-Associated Mutation CXCR4 L329fs
Liu, Q., Pan, C. X., Lopez, L., Gao, J., Velez, D. S., Anaya‐O’Brien, S., Ulrick, J., Littel, P. L., Corns, J. S., Ellenburg, D. T., et al. (2016) · Journal of Clinical Immunology · doi:10.1007/s10875-016-0276-3 · Cited by 32
Role of negative regulation of immune signaling pathways in neutrophil function
Azcutia, V., Parkos, C. A., & Brazil, J. C. (2017) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mir0917-374r · Cited by 33
Congenital Defects in Neutrophil Dynamics
Keszei, M., & Westerberg, L. S. (2014) · Journal of Immunology Research · doi:10.1155/2014/303782 · Cited by 37
“In most kindred gain of function mutations of the chemokine receptor CXCR4 have been identified as the cause of the disease [57].”
BackgroundIbrutinib in Waldenström macroglobulinemia: latest evidence and clinical experience
Castillo, J. J., Palomba, M. L., Advani, R. H., & Treon, S. P. (2016) · Therapeutic Advances in Hematology · doi:10.1177/2040620716654102 · Cited by 32
HLA and KIR Associations of Cervical Neoplasia
Bao, X., Hanson, A., Madeleine, M. M., Wang, S., Schwartz, S. M., Newell, F., Pettersson, U., Hemminki, K., Tiews, S., Steinberg, W., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy483 · Cited by 39
Cutaneous Squamous Cell Carcinoma in the Age of Immunotherapy
Ishitsuka, Y., Hanaoka, Y., Tanemura, A., & Fujimoto, M. (2021) · Cancers · doi:10.3390/cancers13051148 · Cited by 29
“Germline gain-of-function (GOF) mutations in C-X-C chemokine receptor type 4 cause warts, hypogammaglobulinemia, infections and myelocathexis (WHIM) syndrome [69].”
BackgroundMulticenter Experience of Hematopoietic Stem Cell Transplantation in WHIM Syndrome
Laberko, A. L., Деордиева, Е. А., Kriván, G., Goda, V., Bhar, S., Kawahara, Y., Rao, K., Worth, A. J. J., McDermott, D. H., Balashov, D., et al. (2021) · Journal of Clinical Immunology · doi:10.1007/s10875-021-01155-8 · Cited by 30
“Warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome is a rare autosomal dominant primary immunodeficiency (PID), caused by CXCR4 gene mutations [1].”
BackgroundPrimary immunodeficiency update
Pichard, D. C., Freeman, A. F., & Cowen, E. W. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.01.055 · Cited by 31
Leukocyte trafficking in primary immunodeficiencies
Notarangelo, L. D., & Badolato, R. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0808474 · Cited by 31
“Although there is evidence for genetic heterogeneity of WHIM, this rare disorder is usually inherited as an autosomal dominant trait and is a result of heterozygous mutations of CXCR4, a gene encoding for the CXCR4 [42].”
BackgroundCryo-EM structure of monomeric CXCL12-bound CXCR4 in the active state
Liu, Y., Liu, A., Li, X., Liao, Q., Zhang, W., Zhu, L., & Ye, R. D. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114578 · Cited by 29
Toward Digital Periodontal Health: Recent Advances and Future Perspectives
Soheili, F., Delfan, N., Masoudifar, N., Ebrahimni, S., Moshiri, B., Glogauer, M., & Ghafar‐Zadeh, E. (2024) · Bioengineering · doi:10.3390/bioengineering11090937 · Cited by 39
“WHIM syndrome (WHIM) is an inherited immune disorder characterized by symptoms such as warts, low levels of immunoglobulins, and frequent infections [51].”
BackgroundHeterologous regulation of CXCR4 lysosomal trafficking
Caballero, A., Wedemeyer, S. A., Ali, M. S., Rogers, M. R., & Marchese, A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005991 · Cited by 29
“Although these mutant receptors are typically unable to efficiently terminate acute signaling (12), because the degradation motif is intact, they are likely able to undergo efficient lysosomal degradation.”
Background
Metadata
- Authors
- Hernandez, P. A., Gorlin, R. J., Lukens, J. N., Taniuchi, S., Bohinjec, J., Francois, F., Klotman, M. E., & Diaz, G. A.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- University of Minnesota (US)
- Vanderbilt University (US)
- Kansai Medical University (JP)
- Ljubljana University Medical Centre (SI)
- Venue
- Nature Genetics
- Published
- 2003-04-14
- Volume
- 34
- Issue
- 1
- Pages
- 70-74
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2167070743
- Cited by
- 722
- References
- 30
- Citations by year
- 2026: 11 · 2025: 20 · 2024: 40 · 2023: 26 · 2022: 21 · 2021: 25 · 2020: 33 · 2019: 38 · 2018: 39 · 2017: 37 · 2016: 34 · 2015: 37 · 2014: 48 · 2013: 32 · 2012: 35
- FWCI
- 8.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Keywords
- WHIM syndrome, CXCR4, myelokathexis, combined immunodeficiency, neutropenia, hypogammaglobulinemia, HPV infection, calcium flux, autosomal recessive inheritance, genetic heterogeneity, cell-mediated immunity
- MeSH terms
- Agammaglobulinemia, B-Lymphocytes, Base Sequence, Chromosomes, Human, Pair 2, DNA, DNA Mutational Analysis, Female, Humans, Immunologic Deficiency Syndromes, Genetic Linkage, Male, Models, Molecular, Molecular Sequence Data, Mutation, Neutropenia, Pedigree, Warts, Receptors, CXCR4, Calcium Signaling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.